Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 136, Issue -, Pages 70-83Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejpb.2018.12.010
Keywords
-
Categories
Funding
- Innovative Medicines Initiative Joint Undertaking [115369]
- European Union
- Fonds voor Wetenschappelijk Onderzoek Vlaanderen [FWO - 12R2119N]
- COST (European Cooperation in Science and Technology) [CA16205]
Ask authors/readers for more resources
The availability of in vitro tools that are constructed on the basis of a detailed knowledge of key aspects of gastrointestinal (GI) physiology and their impact on formulation performance and subsequent drug release behaviour is fundamental to the success and efficiency of oral drug product development. Over the last six years, the development and optimization of improved, biorelevant in vitro tools has been a cornerstone of the IMI OrBiTo (Oral Biopharmaceutics Tools) project. By bringing together key industry and academic partners, and by linking tool development and optimization to human studies to understand behaviour at the formulation/GI tract interface, the collaboration has enabled innovation, optimization and implementation of the requisite biorelevant in vitro tools. In this paper, we present an overview of the in vitro tools investigated during the collaboration and offer a perspective on their future use in enhancing the development of new oral drug products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available